SRC
SRC (proto-oncogene tyrosine-protein kinase Src, also known as c-src, ASV and SRC1) is a non-receptor tyrosine kinase of the SRC subfamily. It is the cellular homologue of the Rous sarcoma virus v-src gene and has been linked to embryonic development and cell growth. Browse Assay Genie's current range of SRC research reagents below, or read on for the biology behind the target.
SRC is a non-receptor protein tyrosine kinase that transfers phosphate to tyrosine residues on target proteins. Its regulation depends on intramolecular interactions between its SH3 domain, SH2 domain and kinase domain. UniProt describes an isoform with higher basal activity than isoform 1, possibly because weakened intramolecular contacts promote autophosphorylation of Tyr-419 and subsequent activation. In this isoform the SH3 domain binds the linker between the SH2 and kinase domains with reduced affinity, which may account for the increased basal activity. The same isoform has altered substrate specificity, with weak affinity for synaptophysin and for peptide substrates containing class I or class II SH3 domain-binding motifs, and it plays a role in neurite elongation.
The SRC protein belongs to the protein kinase superfamily, Tyr protein kinase family, SRC subfamily. HGNC places the SRC gene in the groups of SH2 domain containing proteins, Src family tyrosine kinases and SH3 domain containing proteins. UniProt records a broad subcellular distribution: the cell membrane, inner mitochondrial membrane, nucleus, cytoskeleton, perinuclear cytoplasm, focal adhesions and other cell junctions. Orthologues are named Src in both mouse and rat. NCBI Gene reports two transcript variants that encode the same protein.
The gene is highly similar to the v-src gene of Rous sarcoma virus, which explains the official previous name 'v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog' and the alias c-src. As a proto-oncogene, SRC may help regulate embryonic development and cell growth. Its activity can be inhibited by phosphorylation by c-SRC kinase, and mutations in the gene could be involved in the malignant progression of colon cancer.
As the cellular counterpart of a viral oncogene, SRC is studied in cell growth control, and its mutations may contribute to colon cancer progression.
SRC is a prototype SRC-subfamily kinase, regulated through its SH2, SH3 and kinase domains and by inhibitory phosphorylation.
A SRC isoform with raised basal kinase activity and altered substrate preference plays a role in neurite elongation.
SRC localises to focal adhesions, cell junctions and the cytoskeleton, making it relevant to studies of cell structure and junction biology.
SRC is a non-receptor protein tyrosine kinase. It may regulate embryonic development and cell growth, and a UniProt-described isoform with higher basal activity plays a role in neurite elongation. Its activity can be inhibited by phosphorylation by c-SRC kinase.
SRC is also called c-src, ASV and SRC1, and UniProt names it proto-oncogene tyrosine-protein kinase Src. Its previous HGNC name was v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog, reflecting its similarity to the Rous sarcoma virus gene.
Mouse and rat both carry an orthologous gene named Src. NCBI Gene notes that mutations in SRC could be involved in the malignant progression of colon cancer. Check the datasheet of any product for its validated reactivity.
Other Src family kinases, the regulatory kinase CSK and substrate-related targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P12931; product specifications from Assay Genie datasheets.